1. Home
  2. FNUC vs MCRB Comparison

FNUC vs MCRB Comparison

Compare FNUC & MCRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

FNUC

Frontier Nuclear and Minerals Inc. Common Shares

N/A

Current Price

$1.95

Market Cap

62.6M

ML Signal

N/A

Logo Seres Therapeutics Inc.

MCRB

Seres Therapeutics Inc.

HOLD

Current Price

$5.69

Market Cap

71.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FNUC
MCRB
Founded
2018
2010
Country
Canada
United States
Employees
N/A
N/A
Industry
Other Metals and Minerals
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
62.6M
71.0M
IPO Year
2021
2015

Fundamental Metrics

Financial Performance
Metric
FNUC
MCRB
Price
$1.95
$5.69
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$14.00
AVG Volume (30 Days)
586.4K
52.6K
Earning Date
06-24-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$789,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.76
$6.01
52 Week High
$2.82
$29.98

Technical Indicators

Market Signals
Indicator
FNUC
MCRB
Relative Strength Index (RSI) 42.10 25.77
Support Level $1.92 N/A
Resistance Level $2.52 $9.53
Average True Range (ATR) 0.24 0.68
MACD -0.04 -0.13
Stochastic Oscillator 22.35 0.40

Price Performance

Historical Comparison
FNUC
MCRB

About FNUC Frontier Nuclear and Minerals Inc. Common Shares

Frontier Nuclear and Minerals Inc is developing a U.S.-focused front-end nuclear fuel cycle company through a portfolio of U.S. uranium exploration and development projects in Wyoming, Colorado, and Utah, together with investments in next-generation uranium enrichment and small modular reactors. Frontier Nuclear is actively evaluating value-accretive investment opportunities in other sectors of the domestic U.S. nuclear fuel cycle. The group is developing a portfolio of critical minerals projects in America, Canada, and Namibia, including uranium, tantalum, cesium, and lithium. Its projects are Engo Valley, Pine Ridge, Shatford Lake, Snow Lake Lithium, and Tallahassee.

About MCRB Seres Therapeutics Inc.

Seres Therapeutics Inc is a clinical-stage biotechnology company focused on the development of live biotherapeutic candidates. Its pipeline includes candidates such as SER-155 and SER-603, aimed at preventing and treating bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases. The company operates as a single reportable segment, mainly developing microbiome-based therapies targeting bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases.

Share on Social Networks: